“Nube” es una galaxia enana casi invisible descubierta por un equipo internacional de investigación. Su brillo es tan débil que ha pasado desapercibida en los distintos cartografiados previos de esa parte del cielo, como si de un fantasma se tratase. Esto se debe a …
Una galaxia casi invisible que desafía el modelo de la materia oscura Read More »
Unos científicos han desarrollado una nueva batería de litio que puede ser cargada y descargada al menos 6.000 veces manteniendo un rendimiento aceptable, y cuyo proceso de recarga tarda tan solo unos diez minutos. Este avance es obra de un equipo integrado, entre otros, por L …
Batería de litio recargable miles de veces y en minutos Read More »
La NASA ha anunciado cambios en las próximas misiones Artemis, que sentarán las bases para la exploración científica a largo plazo de la Luna, el aterrizaje de la primera mujer y la primera persona no blanca en la superficie lunar, y la preparación de expediciones …
Las primeras misiones lunares Artemis con tripulación Read More »
Celltrion, Inc. announced the next phase of its strategic transformation from a developer of the world’s first monoclonal antibody biosimilar to an innovative company focused on new drug development at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, Calif.
Mirum Pharmaceuticals, Inc. announced that on January 10, 2024, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 50,950 shares of common stock and 25,480 restricted stock units to seven new employees under Mirum’s 2020 Inducement Plan.
Ascentage Pharma announced that Dr. Dajun Yang, the company’s Chairman and CEO, gave a speech at the 42nd Annual J.P. Morgan Healthcare Conference.
Ascentage Pharma Presented at 42nd Annual J.P. Morgan Healthcare Conference Read More »
HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that the New Drug Application (“NDA”) for sovleplenib for the treatment of adult patients with primary immune thrombocytopenia (“ITP”) has been accepted for review and granted priority review by the China National Medical Products Administration (“NMPA”).
The BioSpace team is recording from San Francisco as they bring you the the latest highlights from Day 3 at JPM2024.
Gilead’s stock traded lower on news that claims will proceed that allege the company delayed the development of newer, safer HIV drugs in order to maximize profits.
Gilead Sciences Must Face Consumer Claims Over Older, Lower-Quality Drugs, Court Rules Read More »
For experts on Boston Consulting Group’s generative AI panel at the Biotech Showcase, effectively using the technology in the biotech industry will be a collaborative process.
BCG Panel: ‘No Single Approach’ to Maximizing Generative AI in Biotech and Healthcare Read More »
